Glaukos

$84.91
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.06 (-0.08%) As of 3:42 PM UTC today

Why Robinhood?

You can buy or sell Glaukos and other stocks, options, and ETFs commission-free!

About GKOS

Glaukos Corporation, also called Glaukos, is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard Hill on July 14, 1998 and is headquartered in San Clemente, CA. The listed name for GKOS is Glaukos Corporation.

CEO

Thomas William Burns

Employees

600

Headquarters

San Clemente, California

Founded

1998

Market Cap

3.97B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

534.87K

High Today

$86.31

Low Today

$84.70

Open Price

$85.74

Volume

39.84K

52 Week High

$90.71

52 Week Low

$23.31

Collections

Analyst Ratings

27%

of 11 ratings

Buy

27%

Hold

55%

Sell

18%

GKOS Earnings

-$0.76

-$0.51

-$0.25

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Feb 25, After Hours